ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,003, issued on Sept. 16, was assigned to Myriad Women's Health Inc. (South San Francisco, Calif.).
"Methods and compositions for enrichment of target polynucleotides" was invented by Henry H. Lai (South San Francisco, Calif.) and Clement S. Chu (South San Francisco, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "High-fidelity, high-throughput nucleic acid sequencing enables healthcare practitioners and patients to gain insight into genetic variants and potential health risks. However, previous methods of nucleic acid sequencing often introduces sequencing errors (for example, mutations that arise during the preparation of a nucleic acid libr...